Biogen
Phone: +1 781-464-2000
| Formerly | Biogen Idec Inc. (2003–2015) |
|---|---|
| Type | Public company |
| Traded as |
|
| Industry | Biotechnology |
| Founded | 1978 (1978) |
| Founders | Kenneth Murray Phillip Allen Sharp Walter Gilbert Heinz Schaller Charles Weissmann |
| Headquarters | Cambridge, Massachusetts, U.S. |
| Key people | Stelios Papadopoulos (Chairman) Michel Vounatsos (CEO) |
| Products | Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza |
| Revenue |  US$10.981 billion (2021) |
| Operating income | US$2.84 billion (2021) |
| Net income | US$1.727 billion (2021) |
| Total assets | US$23.877 billion (2021) |
| Total equity |  US$10.96 billion (2021) |
| Number of employees | 9,100 (2020) |
| Website | biogen.com |
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
For detailed contact information visit location pages below.
Biogen's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Biogen
-
BiogenHar ikke rekruttert ennå
-
BiogenRekrutteringPostpartum depresjonForente stater
-
BiogenRekrutteringFrivillig friskForente stater
-
BiogenRekruttering
-
BiogenRekruttering
-
BiogenRekrutteringPrimær membranøs nefropatiAustralia, Taiwan, Kina, Forente stater, Japan, Argentina, Brasil, Malaysia, India, Sør -Korea
-
BiogenFullført
-
BiogenAktiv, ikke rekrutterendeSpinal muskelatrofiForente stater, Ungarn, Japan, Italia, Tyskland
-
BiogenPåmelding etter invitasjonSubakutt kutan lupus erythematosus | Kronisk kutan lupus erythematosusForente stater, Brasil, Spania, Taiwan, Canada, Frankrike, Tyskland, Japan, Italia, Colombia, Storbritannia, Serbia, Chile, Filippinene, Bulgaria, Kina, Sverige, Sveits, Mexico, Sør -Korea, Argentina, Ungarn, Slovakia, Polen, Portugal